COVID-19: Immunology and treatment options
S Felsenstein, JA Herbert, PS McNamara… - Clinical …, 2020 - Elsevier
The novel coronavirus SARS-CoV2 causes COVID-19, a pandemic threatening millions. As
protective immunity does not exist in humans and the virus is capable of escaping innate …
protective immunity does not exist in humans and the virus is capable of escaping innate …
Current status of potential therapeutic candidates for the COVID-19 crisis
J Zhang, B Xie, K Hashimoto - Brain, behavior, and immunity, 2020 - Elsevier
Abstract As of April 15, 2020, the ongoing coronavirus disease 2019 (COVID-2019)
pandemic has swept through 213 countries and infected more than 1,870,000 individuals …
pandemic has swept through 213 countries and infected more than 1,870,000 individuals …
[HTML][HTML] SARS-CoV-2 inflammatory syndrome. Clinical features and rationale for immunological treatment
M Prete, E Favoino, G Catacchio, V Racanelli… - International Journal of …, 2020 - mdpi.com
The current pandemic coronavirus, SARS-CoV-2, is a global health emergency because of
its highly contagious nature, the great number of patients requiring intensive care therapy …
its highly contagious nature, the great number of patients requiring intensive care therapy …
VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy
M Magnol, L Couvaras, Y Degboé, E Delabesse… - …, 2021 - academic.oup.com
DEAR EDITOR, Beck et al.[1] recently identified a genetic disorder that connects seemingly
unrelated adult-onset inflammatory syndromes as VEXAS syndrome. We report a case of …
unrelated adult-onset inflammatory syndromes as VEXAS syndrome. We report a case of …
[HTML][HTML] Intravenous immunoglobulins as immunomodulators in autoimmune diseases and reproductive medicine
Intravenous administration of immunoglobulins has been routinely used for more than 60
years in clinical practice, developed initially as replacement therapy in immunodeficiency …
years in clinical practice, developed initially as replacement therapy in immunodeficiency …
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from systematic literature review and from real life experience
Introduction Intravenous immunoglobulins (IVIG) are a new therapeutic approach in
systemic sclerosis SSc. An immunomodulatory and antifibrotic activity has been postulated …
systemic sclerosis SSc. An immunomodulatory and antifibrotic activity has been postulated …
[HTML][HTML] Current and innovated managements for autoimmune bullous skin disorders: An overview
KY Chu, HS Yu, S Yu - Journal of Clinical Medicine, 2022 - mdpi.com
Autoimmune bullous skin disorders are a group of disorders characterized by the formation
of numerous blisters and erosions on the skin and/or the mucosal membrane, arising from …
of numerous blisters and erosions on the skin and/or the mucosal membrane, arising from …
Biomaterials-based opportunities to engineer the pulmonary host immune response in COVID-19
The COVID-19 pandemic caused by the global spread of the SARS-CoV-2 virus has led to a
staggering number of deaths worldwide and significantly increased burden on healthcare as …
staggering number of deaths worldwide and significantly increased burden on healthcare as …
Scleromyxedema
JHO Hoffmann, AH Enk - JDDG: Journal der Deutschen …, 2020 - Wiley Online Library
Scleromyxedema is a rare, cutaneous deposition disorder from the group of mucinoses,
which can affect multiple organs and is virtually always associated with a monoclonal …
which can affect multiple organs and is virtually always associated with a monoclonal …
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis
N Farina, C Campochiaro, A Lescoat… - Expert Review of …, 2023 - Taylor & Francis
ABSTRACT Introduction Systemic sclerosis (SSc) is a systemic disease encompassing
autoimmunity, vasculopathy, and fibrosis. SSc is still burdened by high mortality and …
autoimmunity, vasculopathy, and fibrosis. SSc is still burdened by high mortality and …